What if safe, everyday medications could be repurposed to make cancer treatments more effective?

In this episode, we sit down with Dr. Charles Meakin, MD a former radiation oncologist and now founder of Meakin Metabolic Care, to explore how off-label medications and metabolic therapy are being used to support people facing cancer.

Dr. Meakin shares:

• 
  

  His journey from conventional oncology to integrative, metabolic-focused care

  
  


• 
  

  How common drugs like metformin, doxycycline, and mebendazole may help target cancer pathways

  
  


• 
  

  The difference between fenbendazole and mebendazole, and what patients should know

  
  


• 
  

  Why multi-drug, low-dose combinations can sometimes improve outcomes

  
  


• 
  

  The risks of self-prescribing without medical oversight

  
  


• 
  

  How mindset, lifestyle, and medical supervision all work together in metabolic healing

  
  

Whether you’re exploring complementary options alongside standard of care, or simply curious about the science behind repurposed medications, this conversation offers grounded, hopeful, and practical insights.

👉 Learn more about Dr. Meakin’s Cancer Metabolic Optimization Program and book a free call with an advisor at Heal Navigator.